Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




POC 3D Imaging Platform Enables Real-Time Assessment of Surgical Specimens in OR

By HospiMedica International staff writers
Posted on 06 Oct 2023

Lumpectomies often come with the risk of re-excisions, or additional surgeries, which not only affect the patient's healing and appearance but also result in a higher financial burden. More...

Now, a high-resolution 3D specimen imaging system uses an advanced reconstruction algorithm to offer real-time detailed surgical information to clinicians treating breast cancer, promising to cut down on re-excisions in breast-conserving surgery.

Clarix Imaging’s (Chicago, IL, USA) VSI-360 volumetric specimen imaging system is a state-of-the-art, point-of-care 3D imaging platform that provides real-time evaluation of surgical samples right inside the operating room. The FDA-cleared volumetric specimen imager is Clarix Imaging’s first flagship product and provides unparalleled clarity in visualizing intraoperative specimen margin during breast cancer surgeries like lumpectomies. With its precise technology and workflow-centric software, VSI-360 allows surgeons and radiologists to generate an accurate 3D model of the specimen and view the tumor in thin image slices, preventing overlapping tissues from obscuring the margins.

Clarix Imaging’s groundbreaking innovation is based on its proprietary image reconstruction technology which enables high-quality, isotropic imaging in a considerably shorter scan time. This leap in technology has allowed Clarix to develop a portable system that fits seamlessly into the busy workflow of an operating room, enabling quick confirmation that the correct tissue has been removed, thereby streamlining the surgical process. Clarix Imaging’s expertise in volumetric imaging, coupled with its expanding collection of 3D images of breast cancer, has the potential to open up new avenues for clinical research and applications, particularly with the integration of artificial intelligence, ultimately raising the standard of patient care.

Related Links:
Clarix Imaging


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Head Rest
Medifa 61114_3
LED Surgical Lamp
ACEMST35/57
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.